FDA Clears Medtronic's And Boston Scientific's Remote Cardiac Monitors, Approves Abbott’s Bluetooth-Compatible ICDs

 
• By Reed Miller

Medtronic will launch the LINQ II remotely programmable, insertable cardiac monitor in the US and Europe this summer following FDA clearance. Boston Scientific plans to launch its LUX-Dx monitor later this year. The agency also approved Abbott's Gallant ICD and CRT-D devices, which communicate with Abbott's myMerlinPulse mobile app.

Approved stamp

The US Food and Drug Administration authorized new cardiac devices from Medtronic plc, Boston Scientific Corporation and Abbott Laboratories designed to help physicians monitor their patients remotely through mobile device apps.

Medtronic announced plans to launch the LINQ II insertable cardiac monitor in the US later this summer following 510(k) clearance from the FDA on 7 July

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation